Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 21;17(1):e0262694.
doi: 10.1371/journal.pone.0262694. eCollection 2022.

HIV prevalence and incidence among men who have sex with men and transgender women in Bangkok, 2014-2018: Outcomes of a consensus development initiative

Frits van Griensven  1   2 , Nittaya Phanuphak  1 , Chomnad Manopaiboon  3   4 , Eileen F Dunne  3   5 , Donn J Colby  1 , Pannee Chaiphosri  6 , Reshmie Ramautarsing  1 , Philip A Mock  3 , Thomas E Guadamuz  7 , Ram Rangsin  8 , Kanya Benjamaneepairoj  9 , Panus Na Nakorn  10 , Ravipa Vannakit  11 , Jan Willem de Lind van Wijngaarden  11 , Matthew Avery  9 , Stephen Mills  9
Affiliations

HIV prevalence and incidence among men who have sex with men and transgender women in Bangkok, 2014-2018: Outcomes of a consensus development initiative

Frits van Griensven et al. PLoS One. .

Abstract

To reach its goal of ending AIDS by 2030, Thailand has adopted antiretroviral treatment as prevention and HIV pre-exposure prophylaxis for men who have sex with men (MSM) and transgender women (TGW) as its core HIV control strategy. However, in the absence of reliable epidemiologic indicators, the impact of these policies on the course of the HIV epidemic in these groups remains unknown. To help answer this question, we formulated an HIV epidemic consensus initiative for Bangkok, Thailand, to analyze epidemiologic and program data and reach agreement between experts and stakeholders on the evolving state of the HIV epidemic among MSM and TGW. A customized Delphi process was used to consult and consolidate viewpoints of experts and stakeholders. Experts presented and discussed HIV prevalence and incidence data from recent and ongoing studies among MSM and TGW in Bangkok (2014 to 2018) during a meeting with stakeholders representing government, donors, and civil society. Agreement about the course of the HIV epidemic among MSM and TGW was attained by voting consensus. Based on presented data, meeting participants agreed that HIV prevalence and incidence had decreased among Bangkok MSM from 2014 to 2018. Despite these declines, HIV prevalence and incidence were found to remain high. This was particularly the case among younger MSM. Participants agreed that there was no evidence for a decrease in HIV prevalence and incidence among Bangkok TGW. Introduction of antiretroviral treatment as prevention and HIV pre-exposure prophylaxis may have contributed to these declines. However, HIV prevalence and incidence remained high, and no signs of a decrease were reported among Bangkok TGW. At the current rate of new HIV infections in MSM and TGW, Thailand will not reach its goal of ending AIDS by 2030. This HIV consensus initiative may serve as a model for building agreement and advocacy on epidemiologic and program data and their implications for a large metropolitan city.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. HIV prevalence among men who have sex with men, integrated behavioral and biological surveillance, Bangkok, 2014–2018, by age group.
Fig 2
Fig 2. Quarterly HIV prevalence among men who have sex with men attending HIV testing and counseling services at the Silom Community Clinic, Bangkok, 2014–2018, by age group.
Fig 3
Fig 3. Quarterly HIV incidence among men who have sex with men attending HIV testing and counseling services at the Silom Community Clinic, Bangkok, 2014–2018, by age group.
Fig 4
Fig 4. HIV prevalence among transgender women, integrated behavioral and biological surveillance, Bangkok, 2014–2018, by age group.
See this image and copyright information in PMC

References

    1. van Griensven F, Phanuphak N, Srithanaviboonchai K. Biomedical HIV prevention research and epidemic control in Thailand: two sides of the same coin. Sex Health. 2014;11(2):180–99. doi: 10.1071/SH13119 - DOI - PubMed
    1. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal D. Impact of Thailand’s HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet. 1994;344(8917):243–5. Epub 1994/07/23. S0140-6736(94)93004-X. doi: 10.1016/s0140-6736(94)93004-x . - DOI - PubMed
    1. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al.. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999;353(9155):773–80. Epub 1999/08/25. doi: 10.1016/s0140-6736(98)10411-7 . - DOI - PubMed
    1. Lolekha R, Boonsuk S, Plipat T, Martin M, Tonputsa C, Punsuwan N, et al.. Elimination of Mother-to-Child Transmission of HIV—Thailand. MMWR Morbidity and mortality weekly report. 2016;65(22):562–6. Epub 2016/06/10. doi: 10.15585/mmwr.mm6522a2 . - DOI - PubMed
    1. Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K, et al.. National expansion of antiretroviral treatment in Thailand, 2000–2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr. 2009;50(5):506–12. Epub 2009/02/19. doi: 10.1097/QAI.0b013e3181967602 . - DOI - PubMed

Publication types